Increased red cell distribution width predicts occlusion of the infarct-related artery in STEMI


Akboga M. K. , Yayla C., Yilmaz S., Sen F., Balci K. G. , Ozcan F., ...More

SCANDINAVIAN CARDIOVASCULAR JOURNAL, vol.50, no.2, pp.114-118, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 50 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.3109/14017431.2015.1119303
  • Journal Name: SCANDINAVIAN CARDIOVASCULAR JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.114-118
  • Keywords: red cell distribution width, myocardial infarction, STEMI, Infarct-related artery patency, ELEVATION MYOCARDIAL-INFARCTION, C-REACTIVE PROTEIN, PRIMARY ANGIOPLASTY, HEART-FAILURE, INFLAMMATION, ASSOCIATION, MORTALITY, RISK, ATHEROSCLEROSIS, INTERVENTION
  • Gazi University Affiliated: Yes

Abstract

Objective Infarct-related artery (IRA) patency yields a better outcome in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Red cell distribution width (RDW) emerges as a marker of adverse cardiovascular events and mortality in STEMI. Therefore, we aimed to assess the relationship between IRA patency and RDW value on admission in patients with STEMI undergoing primary PCI. Methods A total of 564 patients with STEMI undergoing primary PCI were recruited in this study. According to thrombolysis in myocardial infarction (TIMI) flow grade in the IRA before PCI, the study population was divided into two groups as TIMI 0 or 1 group (occluded IRA, n = 398) and TIMI 2 or 3 group (patent IRA, n = 166). Results RDW was significantly higher in the occluded IRA group (15.1 +/- 1.7 versus 13.4 +/- 1.3, p < 0.001) as compared to the patent IRA group. White blood cell (WBC) count, platelet count, creatine kinase-myocardial band (CK-MB) and troponin-I levels were also significantly higher in the occluded IRA group (p < 0.05). Moreover, RDW showed positive correlations with troponin-I (r = 0.397, p < 0.001), CK-MB (r = 0.344, p < 0.001) and WBC (r = 0.219, p < 0.001). In multivariate regression analysis, RDW (OR: 0.483, 95% CI: 0.412-0.567, p < 0.001) and WBC count were significantly and independently associated with IRA patency. Conclusions Our findings suggested that RDW value and WBC count on admission were independent predictors of IRA patency in patients with STEMI. As RDW is an easily available, simple and cheap biomarker, it can be used in daily practice as a novel predictor for IRA patency.